Here, we showed that ERK1/2/AP-1/Sp1/ezrin signaling was involved in TPA-mediated motility of ESCC cells, suggesting that VIL2 might be an important downstream effector of TPA. Here, JUN is linked to esophageal squamous cell carcinoma.